Noninvasive Evaluation and Clinical Value Prediction of Tumor-Infiltrating Neutrophil-to-T-Cell Ratio in Pancreatic Ductal Adenocarcinoma

Researchers used pancreatic ductal adenocarcinoma (PDAC) patients from TCGA, CPTAC, and multiple centers to investigate and validate the relationship between the prognosis and tumor-infiltrating neutrophil-to-T-cell ratio (NTR) in the tumor immune microenvironment, including the correlation of NTR with chemotherapy response in PDAC.